2nd Annual Biologics World Taiwan 2014
Organization: IMAPAC Private Limited
Venue: Grand Hyatt Taipei
Event Date/Time: Feb 26, 2014 | End Date/Time: Feb 27, 2014 |
Description
In Februray 2014, 2nd Annual Biologics World Taiwan - the ONLY biologics and biosimilars focused platform in Taiwan - will bring together Taiwanese and international biopharma leaders, innovative biotechs, and technocrats.
2nd Annual Biologics World Taiwan brings to you:
- The most targeted platform to meet Taiwanese and international biologics manufacturers
- Case studies and discussions from senior level decision makers who will influence the direction of Taiwan's biologics industry
- Both strategic and technology-focused biologics development in Taiwan
Key topics include:
- Opportunities and challenges facing Taiwan's Biologics Industry
- Innovation highlights: Biobetters and novel biologics development in Taiwan
- Innovation highlights: Vaccine Development in Taiwan
- Biomanufacturing upstream best practices
- Biomanufacturing downstream best practices
- Operational excellence and PAT
- Crystalballing the future of Taiwan's biologics industry
Key speakers include:
- Dou Chang Lin, Chief Technology Officer, Biologic R&D, Luye Pharma Group
- Karen Wen, President, Mycenax Biotech, Taiwan
- Racho Jordanov, Founder, President and CEO, JHL Biotech
- Yariv Hefez, Vice President of Business Development, Strategy, Portfolio Management and Partnering, Merck Serono
- Dr. Jimmy Zhang, Managing Director, MSD Early Investments
- Dr. Youe-Kong Shue, Vice Chairman, OBO Pharma
- Juine-Ruey Chen, Head of R&D, Adimmune, and many more!